Cited by 12

The DOI matches its Crossref record.

MicroRNA-27a Modulates HCV Infection in Differentiated Hepatocyte-Like Cells from Adipose Tissue-Derived Mesenchymal Stem Cells

Choi, Jung Eun, Hur, Wonhee, Kim, Jung-Hee, Li, Tian Zhu, Lee, Eun Byul, Lee, Sung Won, Kang, Wonseok, Shin, Eui-Cheol, Wakita, Takaji, Yoon, Seung Kew·2014·PLoS ONE

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0091958

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 42

  1. MP Walker, 2003, Hepatitis C virus therapies: current treatments, targets and future perspectives, Antivir Chem Chemother, 14, 1, 10.1177/095632020301400101 · DOI
  2. T Kagawa, 2010, Pegylated interferon and ribavirin treatment for hepatitis C virus infection, Hepat Res Treat, 2010, 275
  3. A Ploss, 2010, Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures, Proc Natl Acad Sci U S A, 107, 3141, 10.1073/pnas.0915130107 · DOI
  4. P Keskinen, 1999, Impaired antiviral response in human hepatoma cells, Virology, 263, 364, 10.1006/viro.1999.9983 · DOI
  5. T Wakita, 2005, Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nat Med, 11, 791, 10.1038/nm1268 · DOI
  6. T Yoshida, 2011, Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection, Biochem Biophys Res Commun, 416, 119, 10.1016/j.bbrc.2011.11.007 · DOI
  7. P Roelandt, 2012, Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus, J Hepatol, 57, 246, 10.1016/j.jhep.2012.03.030 · DOI
  8. RE Schwartz, 2012, Modeling hepatitis C virus infection using human induced pluripotent stem cells, Proc Natl Acad Sci U S A, 109, 2544, 10.1073/pnas.1121400109 · DOI
  9. M Sourisseau, 2013, Hepatic Cells Derived From Induced Pluripotent Stem Cells of Pigtail Macaques Support Hepatitis C Virus Infection, Gastroenterology
  10. X Wu, 2012, Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation, PLoS Pathog, 8, e1002617, 10.1371/journal.ppat.1002617 · DOI
  11. JM Gottwein, 2007, Hepatitis C virus host cell interaction uncovered, Proc Natl Acad Sci U S A, 104, 13215, 10.1073/pnas.0705890104 · DOI
  12. MT Mitjavila-Garcia, 2005, Embryonic stem cells: meeting the needs for cell therapy, Adv Drug Deliv Rev, 57, 1935
  13. N Maherali, 2008, Guidelines and techniques for the generation of induced pluripotent stem cells, Cell Stem Cell, 3, 595, 10.1016/j.stem.2008.11.008 · DOI
  14. PA Zuk, 2001, Multilineage cells from human adipose tissue: implications for cell-based therapies, Tissue Eng, 7, 211, 10.1089/107632701300062859 · DOI · Paper page
  15. A Banas, 2007, Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes, Hepatology, 46, 219, 10.1002/hep.21704 · DOI · Paper page
  16. MF Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 · DOI · Paper page
  17. R Talens-Visconti, 2006, Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells, World J Gastroenterol, 12, 5834, 10.3748/wjg.v12.i36.5834 · DOI
  18. PC Baer, 2012, Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity, Stem Cells Int, 2012, 812693
  19. V Ambros, 2001, microRNAs: tiny regulators with great potential, Cell, 107, 823, 10.1016/S0092-8674(01)00616-X · DOI
  20. Y Zeng, 2012, MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2, FEBS Lett, 586, 2375, 10.1016/j.febslet.2012.05.049 · DOI
  21. Z Zhang, 2012, Expression of microRNAs during chondrogenesis of human adipose-derived stem cells, Osteoarthritis Cartilage, 20, 1638, 10.1016/j.joca.2012.08.024 · DOI
  22. J Romano, 2011, MicroRNA regulation in mammalian adipogenesis, Exp Biol Med, 236, 997, 10.1258/ebm.2011.011101 · DOI
  23. Y Chen, 2010, Hepatic differentiation of liver-derived progenitor cells and their characterization by microRNA analysis, Liver Transpl, 16, 1086, 10.1002/lt.22111 · DOI
  24. JC Cheng, 2012, Let-7b is a novel regulator of hepatitis C virus replication, Cell Mol Life Sci, 69, 2621, 10.1007/s00018-012-0940-6 · DOI
  25. T Shirasaki, 2013, MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells, J Virol, 87, 5270, 10.1128/JVI.03022-12 · DOI
  26. C Jopling, 2010, Targeting microRNA-122 to Treat Hepatitis C Virus Infection, Viruses, 2, 1382, 10.3390/v2071382 · DOI
  27. M Sidorkiewicz, 2010, Expression of microRNA-155 precursor in peripheral blood mononuclear cells from Hepatitis C patients after antiviral treatment, Acta Virol, 54, 75, 10.4149/av_2010_01_75 · DOI
  28. W Hou, 2010, MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins, Hepatology, 51, 1494, 10.1002/hep.23401 · DOI
  29. Y Murakami, 2009, Regulation of the hepatitis C virus genome replication by miR-199a, J Hepatol, 50, 453, 10.1016/j.jhep.2008.06.010 · DOI
  30. H Ishida, 2011, Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway, Biochem Biophys Res Commun, 412, 92, 10.1016/j.bbrc.2011.07.049 · DOI
  31. H Kambara, 2012, Estalishment of novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR-122, J Virol, 86, 1382, 10.1128/JVI.06242-11 · DOI
  32. T Fukuhara, 2012, Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus, J Virol, 86, 7918, 10.1128/JVI.00567-12 · DOI
  33. CM Narbus, 2011, HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle, J Virol, 85, 12087, 10.1128/JVI.05843-11 · DOI
  34. W Hur, 2012, Oleuropein reduces free fatty acid-induced lipogenesis via lowered extracellular signal-regulated kinase activation in hepatocytes, Nutr Res, 32, 778, 10.1016/j.nutres.2012.06.017 · DOI
  35. V Dussupt, 2009, The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding, PLoS Pathog, 5, e1000339, 10.1371/journal.ppat.1000339 · DOI · Paper page
  36. CW Kim, 2013, Hepatitis C virus: virology and life cycle, Clin Mol Hepatol, 19, 17, 10.3350/cmh.2013.19.1.17 · DOI
  37. L Cui, 2012, Dynamic microRNA profiles of hepatic differentiated human umbilical cord lining-derived mesenchymal stem cells, PLoS One, 7, e44737, 10.1371/journal.pone.0044737 · DOI
  38. K Okita, 2007, Generation of germline-competent induced pluripotent stem cells, Nature, 448, 313, 10.1038/nature05934 · DOI
  39. CK Huang, 2013, Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR, Biochim Biophys Acta, 1833, 1222, 10.1016/j.bbamcr.2013.01.007 · DOI
  40. M Sundin, 2006, Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual, Bone Marrow Transplant, 37, 1051, 10.1038/sj.bmt.1705368 · DOI
  41. TZ Nazari-Shafti, 2011, Mesenchymal stem cell derived hematopoietic cells are permissive to HIV-1 infection, Retrovirology, 8, 3, 10.1186/1742-4690-8-3 · DOI
  42. T Shirasaki, 2013, MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells, J Virol, 87, 5270, 10.1128/JVI.03022-12 · DOI

Cited by

Sorted by citations

Metadata

Authors
Choi, J. E., Hur, W., Kim, J.-H., Li, T. Z., Lee, E. B., Lee, S. W., Kang, W., Shin, E.-C., Wakita, T., & Yoon, S. K.
Venue
PLoS ONE
Published
2014-05-13
Volume
9
Issue
5
Pages
e91958
ISSN
1932-6203
Cited by
12
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review